XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statement Of Equity - USD ($)
$ in Thousands
Total
Total National Health Investors, Inc. Stockholders’ Equity
Common Stock
Capital in Excess of Par Value
Retained Earnings
Cumulative Dividends
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2023     43,409,841        
Beginning balance at Dec. 31, 2023 $ 1,264,391 $ 1,253,952 $ 434 $ 1,603,757 $ 2,466,844 $ (2,817,083) $ 10,439
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Distributions declared to noncontrolling interests (205)           (205)
Net income, excluding loss attributable to redeemable noncontrolling interest 30,882 30,947     30,947   (65)
Grants of restricted stock (in shares)     15,000        
Share-based compensation 2,155 2,155   2,155      
Dividends declared, per common share (39,082) (39,082)       (39,082)  
Ending balance (in shares) at Mar. 31, 2024     43,424,841        
Ending balance at Mar. 31, 2024 $ 1,258,141 1,247,972 $ 434 1,605,912 2,497,791 (2,856,165) 10,169
Beginning balance (in shares) at Dec. 31, 2024 45,687,942   45,687,942        
Beginning balance at Dec. 31, 2024 $ 1,375,387 1,366,475 $ 457 1,736,831 2,604,829 (2,975,642) 8,912
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Distributions declared to noncontrolling interests (236)           (236)
Net income, excluding loss attributable to redeemable noncontrolling interest 34,060 34,165     34,165   (105)
Grants of restricted stock (in shares)     29,500        
Equity issuance costs (47) (47)   (47)      
Taxes related to net settlement of equity awards (in shares)     (534)        
Taxes related to net settlement of equity awards $ (136) (136)   (136)      
Shares issued on stock options exercised (in shares) 73,984   16,763        
Issuance of common stock (in shares)     960,000        
Issuance of common stock, net $ 65,483 65,483 $ 10 65,473      
Share-based compensation 2,558 2,558   2,558      
Dividends declared, per common share $ (42,024) (42,024)       (42,024)  
Ending balance (in shares) at Mar. 31, 2025 45,687,942   46,693,671        
Ending balance at Mar. 31, 2025 $ 1,435,045 $ 1,426,474 $ 467 $ 1,804,679 $ 2,638,994 $ (3,017,666) $ 8,571